An experimental vaccine developed in Europe to prevent infection by Crimean-Congo hemorrhagic fever virus (CCHFV) has protected cynomolgus macaques in a new collaborative study from National Institutes of Health scientists.
from News Medical Medical Research News Feed https://ift.tt/3qhFFYg
0 Comments